West Pharmaceutical Services, Inc. (WST) is a publicly traded Healthcare sector company. As of May 20, 2026, WST trades at $308.48 with a market cap of $21.51B and a P/E ratio of 40.45. WST moved +0.46% today. Year to date, WST is +9.49%; over the trailing twelve months it is +41.81%. Its 52-week range spans $187.43 to $352.33. Analyst consensus is buy with an average price target of $347.50. Rallies surfaces WST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
West Pharmaceutical Services, Inc. (WST) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. WST moved +0.46% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $308.48 |
| Market Cap | $21.51B |
| P/E Ratio | 40.45 |
| EPS | $7.52 |
| Dividend Yield | 0.22% |
| 52-Week High | $352.33 |
| 52-Week Low | $187.43 |
| Volume | 403.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.22B |
| Net Income | $542.70M |
| Gross Margin | 36.28% |
7 analysts cover WST: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $347.50.